Personalized total neoadjuvant therapy for rectal cancer enhances patient quality of life and reduces bowel dysfunction compared to standard care. Watch-and-wait patients reported significantly lower rates of lower anterior resection syndrome (55.6% vs. 87.5%, p = 0.012) and major symptoms (29.6% vs. 58.3%, p = 0.039). Quality of life scores improved, notably in stool frequency […]
Category: Intestine and Lower Gastrointestinal Tract
Transanal tube placement cuts anastomotic leakage in rectal cancer surgery.
Anastomotic leakage rate was 5% with transanal tube placement vs. 18% without (p = 0.02). Male patients were identified as a risk factor for leakage, while transanal tube placement was protective, especially in middle rectal cancer cases. Consider using transanal tubes alongside indocyanine green imaging for better outcomes in your rectal cancer surgeries. Journal Article […]
New Guidelines Transform Care for Diverticular Disease
Updated global consensus on diverticular disease sets clear treatment pathways for better patient outcomes. High fiber intake protects against symptoms; smoking, obesity, certain medications increase risk. Acute diverticulitis imaging: ultrasound can work in skilled hands, but CT remains the gold standard for complications. Shift focus to individualized surgical approaches aimed at improving quality of life […]
Impact of T and N Stages on Survival in Stage IV Colorectal Cancer
Advanced T and N stages significantly worsen survival in stage IV colorectal cancer, highlighting the need for careful patient stratification. 5-year cancer-specific survival (CSS) is just 20.7%, dropping to 17.4% for T4 and 14.5% for N2. Higher T and N stages independently increase mortality risk, with T4 (HR: 1.33) and N1/N2 (HR: 1.27 and 1.59) […]
Cost Savings with Enhanced Recovery in Colorectal Surgery
Colorectal enhanced recovery after surgery (ERAS) significantly reduces costs and complications compared to conventional care. ERAS leads to a median cost reduction of AUD 2010 per patient (AUD 20,719 vs. AUD 22,729, p=0.008). Patients on ERAS had a shorter median length of stay (5 vs. 6 days, p<0.001) and lower overall complication rates (26.42% vs. […]
Virtual Scale Endoscopy Outperforms Traditional Polyp Measurement
Virtual Scale Endoscopy (VSE) significantly enhances accuracy in colorectal polyp size measurement, improving surgical decisions and patient outcomes. VSE improved measurement accuracy by 14.5% compared to visual assessment. Reduced total misclassifications from 73.6% to 54.3% with VSE. This suggests VSE could be crucial for better polypectomy and surveillance decisions. VSE also minimized overestimation rates from […]
Guidelines Favor taTME Over Laparoscopic Techniques for Rectal Cancer
taTME offers a preferred option for treating low- and selected mid-rectal cancers in appropriate surgical settings. Strong recommendation for taTME over laparoscopic TME (latme) for sphincter-preserving cases. High-risk patients, especially males with BMI > 30, may benefit most from this approach. Surgeons should consider expertise and high-volume centers when making treatment decisions. Shared decision-making with […]
Watch-and-wait safe for rectal tumors beyond exam reach
Watch-and-wait management is viable for rectal cancers not palpable on exam, keeping patient outcomes comparable. 3-year local regrowth-free survival rates: 81.4% for palpable vs. 74.3% for nonpalpable tumors. 3-year disease-free survival rates: 80.8% for palpable vs. 74.3% for nonpalpable tumors. Surgeons can confidently consider watch-and-wait for these cases without compromising efficacy. Initial clinical responses don’t […]
Colorectal Cancer Burden Rising in East Asia: Key Trends and Projections
Colorectal cancer (CRC) incidence and mortality are sharply increasing in East Asia, necessitating targeted surgical interventions and screening. South Korea leads with a 5.29% annual increase in CRC incidence, followed by China at 4.11%. Projections indicate a continued rise in China by 2050, while South Korea’s incidence stabilizes and Japan’s growth slows. Males, particularly in […]
Transforming Rectal Cancer Care: Upfront Surgery Wins
Selected rectal cancer patients can safely skip neoadjuvant therapy and proceed directly to total mesorectal excision. Among 94 patients, 100% had local recurrence-free survival at 3 years; 97% at 5 years. R0 resection achieved in 99%, leading to substantial overall survival rates of 97% at 3 years and 95% at 5 years. This evidence supports […]